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.2012.09.Abstract Background: Insertion of Internal Cardioverter Deﬁbrillator in high risk cardiac
patients can be performed by many anesthetic techniques including local anesthesia with moderate
sedation or general anesthesia. Many studies have proved that intravenous paracetamol infusion is
effective in reducing narcotic requirements in many surgical procedures.
Purpose: The aim of this study was to assess the effect of paracetamol in reducing pain as well as
apnea and upper airway obstruction during conscious sedation for Internal Cardioverter Deﬁbril-
lator placement.
Patients and methods: In this prospective, randomized study, 100 patients undergoing elective
transvenous placement of Internal Cardioverter Deﬁbrillator (ICD) were enrolled in this study.
Pain, respiratory events as apnea and airway obstruction in patients receiving intravenous paracet-
amol infusion 1 g over 30 min have been compared with those receiving fentanyl in a total dose of
1.5 lg/kg.d Specialist Hospital, Prince
52, Saudi Arabia. Tel.: +966
tmail.com (M.A. Khalil).
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42 M.A. Khalil et al.Results: The incidence of airway obstruction was lower in the paracetamol group than in the fen-
tanyl one (P< 0.05). There was also a signiﬁcant difference between the two groups as regards arte-
rial carbon dioxide tension (PCO2), which was signiﬁcantly higher in Group F (48.9 ± 0.63) in
comparison to Group P (45.6 ± 0.64) (P< 0.001) as well as the degree of sedation where the seda-
tion score was 2.2 ± 0.3 in group P. Also, the Visual Analog Scale (VAS) was signiﬁcantly lower in
Group P than in Group F (P< 0.05).
Conclusion: Intravenous paracetamol infusion was effective in reducing pain as well as the inci-
dence of intraoperative respiratory events as upper airway obstruction in high risk cardiac patients
undergoing Internal Cardioverter Deﬁbrillator insertion.
ª 2012 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Many studies have shown that placement of Internal Cardio-
verter Deﬁbrillator (ICD), prevents signiﬁcantly sudden death
in patients with moderate to severe impairment of systolic
function [1,2]. Formerly, the implantation of ICD was per-
formed under general anesthesia, however, the electrophysiol-
ogists tried in a study [3] to place it under local anesthesia with
minimal sedation. Also, it has been proved that there was no
inﬂuence of the type of anesthesia on the deﬁbrillation thresh-
old [4]. Other studies proved the safety and acceptability of
implantation of ICD under local anesthesia with conscious
sedation [5,6]. However, it has been proved that ICD insertion
under conscious sedation may be associated with respiratory
events as apnea and upper airway obstruction [7]. The goal
of this study was to assess the effectiveness of intravenous par-
acetamol as an analgesic, in a trial to reduce the use of intra-
venous opioids in order to minimize the respiratory events
which might happen during ICD placement.2. Patients and methods
2.1. Anesthetic technique
After hospital ethical committee approval and informed writ-
ten consent obtained, we studied 100 patients undergoing elec-
tive transvenous placement of an Internal Cardioverter
Deﬁbrillator (ICD) because of cardiomyopathic ventricle with
severe impairment of systolic function and history of refrac-
tory paroxysmal ventricular tachyarrhythmias (ventricular
tachycardia and/or ventricular ﬁbrillation), this was at Saad
Specialist Hospital, Saudi Arabia, in the period between Janu-
ary 2010 and June 2011. Excluded patients from the study were
those who asked for either local or general anesthesia, those
who developed severe intraoperative myocardial depression
requiring cardiopulmonary resuscitation, patients with renal
or hepatic disease and opioid naı¨ve patients.
Patients were randomly allocated in this prospective study,
into one of two groups: Group F (n= 50) or Fentanyl group
and Group P (n= 50) or paracetamol group. Randomization
was performed according to computer – generated list and the
sequence of randomization was concealed using sequentially
numbered envelopes provided by an independent investigator.
Immediately before starting the surgical procedure, all patients
received 0.02 mg/kg body weight intravenous midazolam. With
the start of the procedure, all patients were given 1 lg/kg bodyweight intravenous fentanyl. In all patients, the surgical site
was inﬁltrated with lidocaine hydrochloride 2%, together with
continuous inﬁltration of the subcutaneous layers as surgery is
progressing up to a maximum of 3 mg/kg of lidocaine. This
was usually performed by the cardiologist performing the ICD
implantation. Success of the local inﬁltration was examined be-
fore the start of the procedure. Before doing the deﬁbrillation
test, patients in Group F, were given an additional dose of
0.5 lg/kg body weight intravenous fentanyl, while patients in
Group P, were given 1 g of intravenous infusion of paracetamol,
infused over 30 min immediately after the surgical incision.
Standardmonitoring techniquewas used in all patients. Elec-
trocardiography electrodes were positioned on the chest wall for
electrocardiographic monitoring. External pads were posi-
tioned on the chest wall and connected to the external deﬁbrilla-
tor for emergency deﬁbrillation if required. Pulse oximetry,
invasive arterial blood pressure monitoring for continuous arte-
rial pressure monitoring and blood gas check for oxygenation
and ventilation and end tidal CO2were used. Facemaskwas ap-
plied to deliver 5 L/min oxygen all through the procedure and
continuing for 2 h postoperatively. End tidal CO2 was assessed
by inserting the sampling CO2 line inside the face mask, close to
the patient’s nose. All intraoperative respiratory events which
had happened, have been recorded including upper airway
obstruction as well as apnea. This had been usually detected
by continuous inspection of the chest movements as well as
counting the respiratory rate per minute in addition to the pres-
ence of any abnormal respiratory sounds denoting upper respi-
ratory tract obstruction. The degree of sedation during the
surgical procedure had been assessed using the Ramsay Seda-
tion Score, rating the degree of sedation from 1, where the pa-
tient may be anxious, agitated or restless, to 6 where there is
no response to painful stimuli. Pain was assessed using the Vi-
sual Analog Scale (VAS), rating the pain intensity on a 10-point
scale from 0 (no pain) to 10 (worst imaginable pain) at the end of
the deﬁbrillation test. After ﬁnishing the surgical procedure, the
patients have been shifted to the recovery room for about
30 min, all throughwith continuousmonitoring, then aftermak-
ing sure about hemodynamic stability, patients had been shifted
to the Intermediate Care Unit (IMC). At any time of develop-
ment of any hemodynamic instability (severe hypotension with
mean arterial blood pressure < 60 mmHg, tachycardia with a
heart rate > 120/min., malignant arrhythmias as ventricular
tachycardia or ventricular ﬁbrillation necessitating deﬁbrilla-
tion), either in the operating roomor in the recovery, this patient
had been excluded from the study together with shifting to the
Intensive Care Unit.
Table 1 Demographic Data.
Group F (n= 50) Group P (n= 50)
AGE (years) 75.9 ± 3.7 74.8 ± 3.3
Weight (kg) 74.7 ± 5.1 73.9 ± 4.7
Sex (M/F) 39/11 42/8
Hypertension 44 40
Diabetes 39 42
Ischemic cardiomyopathy 28 33
Idiopathic cardiomyopathy 22 17
Ejection fraction (%) 27.7 ± 1.5 28.3 ± 1.8
ASA 3/4 26/24 27/23
No signiﬁcant difference between two groups; ASAs: American
Society of Anesthesiologists.





Airway obstruction 39 28*
Apnea 6 1
No respiratory event 5 21*
Spo2 (%) 95.8 ± 0.51 96.0 ± 0.62
PCO2 (mmHg) 48.9 ± 0.63 45.6 ± 0.64*
Ramsay sedation score(1ﬁ 6) 3.1 ± 0.29 2.2 ± 0.3*
Visual Analog Scale (VAS)(0ﬁ 10) 5.1 ± 0.52 3.5 ± 0.33*
* Signiﬁcant difference between two groups (P< 0.05).
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Two types of ICD have been used. The ﬁrst one was a single
chamber ICD which has been used in 20 patients (Virtuoso II
VR, Medtronic). The second type was a dual chamber ICD
which has been used in 80 patients (in 50 patients Lumax 500
DR-T, Biotronic; in 30 patients Protecta XT DR, Medtronic).
The patient was prepped and draped in a standard sterile fash-
ion.Adose ofCefazolinewas administered. The skinwas incised
after local anesthetic inﬁltration and blunt dissection was em-
ployed together with continuous inﬁltration of the subcutane-
ous layers with the local anesthetic. The pocket was formed in
the left pre-pectoral area. The vein was accessed with peel-away
sheath as per the procedure log and theRV leadwas advanced to
RV and ﬁxed at RV lower septum with good parameters as per
the included measurements. The RA lead was advanced to the
RA and ﬁxed to RAAwith good parameters as per the included
measurements. The sheath was then peeled away. The position
of leads was checked in lateral ﬂuoroscopy to ensure correct po-
sition and appropriate course.Maximum output in this location
did not stimulate the diaphragm. Then the leads were secured to
the fascia with 0-silk using the lead sleeve. The leads were then
connected to the generator. The hard ware was placed in the
pocket after it was ﬂushed with antibiotics. The pocket was then
closed in two layers using 2.0 Dexon in reverse interrupted mat-
tress suture. The skin was closed using absorbable 3.0 Dexon in
subcuticular stitch. The wound was dressed with steri strip and
sterile bandage.
2.3. Recommendation/plan
Routine device implant care, including wound care precaution,
PA/LAT chest X-ray and device interrogation on next day
morning of the procedure. Discharge if the patient remains
clinically stable after overnight observation. Routine device
interrogation in 2 months.
2.4. Statistical methods
Data were statistically described in terms of mean ± standard
deviation (±SD), frequencies (number of cases) and percent-
ages when appropriate. Comparison of numerical variables be-
tween the study groups was done using Student t test for
independent samples. For comparing categorical data, Chi
square (v2) test was performed. Exact test was used instead
when the expected frequency is less than 5. p Values less than
0.05 was considered statistically signiﬁcant. All statistical cal-
culations were done using computer programs SPSS (Statisti-
cal Package for the Social Science; SPSS Inc., Chicago, IL,
USA) version 15 for Microsoft Windows.
3. Results
One hundred patients have been enrolled in this prospective
randomized study, where ﬁfty patients were in the fentanyl
group (Group F) and another ﬁfty patients in the paracetamol
one (Group P).
Concerning the preoperative and demographic data, there
were no statistically signiﬁcant differences between the two
groups (Table 1).As regards the intraoperative data, there was a signiﬁcant
difference between the two groups concerning airway obstruc-
tion (P< 0.05) where it happened in 39 patients in Group F in
comparison to 28 patients only in Group P. For apnea, there
was no statistically signiﬁcant difference between the two
groups, however six patients in Group F developed apnea in
comparison to only one patient in Group P. Concerning the
patients who did not develop any intraoperative respiratory
events, there was a signiﬁcant difference (P< 0.05) between
the two groups, where 21 patients in Group P in comparison
to ﬁve patients in Group F (Table 2).
Concerning oxygen saturation, it was insigniﬁcantly higher
in Group P in comparison to Group F (96.0 ± 0.62% versus
95.8 ± 0.51%) (Table 2).
Carbon dioxide tension (PCO2) was signiﬁcantly higher in
Group F (48.9 ± 0.63 mmHg) in comparison to Group P
(45.6 ± 0.64 mmHg) (P< 0.001) denoting more hypoventila-
tion in the former group (Table 2).
Althoughpatients inGroupFwere signiﬁcantlymore sedated
than those in Group P (P< 0.001), these latter were adequately
sedated, where their sedation score was 2.2 ± 0.3 denoting that
they were cooperative, oriented and tranquil (Table 2).
There was a signiﬁcant difference between the two groups
as regards the Visual Analog Scale (VAS) (P< 0.001), where
it was 5.1 ± 0.52 in Group F in comparison to only 3.5 ± 0.33
in Group P, denoting more pain free in this group of patients
(Table 2).
4. Discussion
This study showed that intravenous paracetamolwas effective in
intraoperative pain relief in comparison to Fentanyl in high risk
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ment under conscious sedation. Additionally, paracetamol
had its effect in reducing intraoperative respiratory events as
upper airway obstruction and apnea. Although the incidence
of respiratory events was signiﬁcantly lower in the paracetamol
group than in the Fentanyl one, the incidence was still high,
about 56%, denoting that narcotics have a deleterious respira-
tory effects in such patients with poor myocardial function.
It is well known that old age patients have a limited phys-
iological reserve with a reduced heart rate responsiveness to
hypotension [8]. There is also a greater risk for apnea owing
to the reduced ventilatory responses to hypoxia and hypercap-
nia. The changes in volume of distribution in the elderly pop-
ulation together with changes in bioavailability and receptor
sensitivity, result in alterations in the pharmacokinetics of
many drugs. Because a high percentage of the elderly patients
have prolonged circulation time, longer periods are needed for
additional doses. Therefore, titration to effect is mandatory in
this group of patients [9].
A high percentage of the elderly surgical patients may de-
velop delirium during sedation [10]. Therefore, caution must
be taken during administration of hypnotics and sedatives in
this population. It is important when sedating elderly patients,
to choose drugs with a short half-life, with minimal active
metabolites and limited side effects. A reduction in the stan-
dard doses calculated on mg/kg basis, should be practiced.
The boluses mostly produce respiratory depression and hypo-
tension. Midazolam and fentanyl is a common combination
which has been frequently used for conscious sedation. Owing
to the reduced clearance of these drugs and the increased sen-
sitivity in the elderly patients, lower doses as little as 50% of
the expected dose, should be administered. In addition, boluses
or incremental doses should be delayed [11]. In our study, both
groups of patients received an equal dose of fentanyl, as a
baseline in order to synergize the analgesic effect of the local
anesthetic inﬁltration in the wound area.
Intravenous paracetamol has a quick onset of action reach-
ing a peak concentration after completion of the infusion which
is about 15 min. The analgesic effect starts within 5 min, reaches
its peak after 1 h and lasts for about 4–6 h. Paracetamol is con-
sidered to be an opioid sparing agent and many studies have
showed its effect in reducing the narcotic doses in many surgical
procedures and therefore reducing the untoward effects of nar-
cotics [12–14]. One study showed the effect of repeated doses of
intravenous paracetamol as a signiﬁcant analgesic indistinguish-
able from that of intramuscular morphine [15]. Also, intrave-
nous paracetamol had reduced the PCA morphine
requirements after spinal surgery [16] and hip arthroplasty
[17]. This was in agreement with our study, where the pain score
was signiﬁcantly lower in the patients who received paracetamol
in comparison to those who received fentanyl only. The analge-
sic effects of paracetamol had been attributed to a number of
central analgesic mechanism including opioid-like effects and
activational effects on descending pain inhibitory system.
Many studies have shown the different modalities of the
anesthetic management of patients undergoing Internal Car-
dioverter Deﬁbrillator placement. In the initial experience of
implantation of ICD by electrophysiologists [3], a comparative
study had been done comparing the insertion under either gen-
eral or local anesthesia with sedation. In this study, it has been
proved the feasibility of use of local anesthesia and sedationwith no need for general anesthesia. In a study done by Mar-
quie´ et al. [18], investigating the implantation of ICD under
minimal sedation, it has been proved that implantation can
be done under minimal sedation even for the deﬁbrillation test.
In this study, a comparison had been done between minimal
sedation and short general anesthesia and minimal sedation
was effective during performing the deﬁbrillation test. Another
study done by Pinosky et al. proved also that intravenous seda-
tion for the placement of ICD is a safe and effective technique
[5]. A study done by Fox et al. [6], conﬁrmed that ICD place-
ment under local anesthesia with sedation is safe and accept-
able to patients and that general anesthesia is no longer
required for such procedure.
A study was done by Chow et al. [7], to detect the respiratory
events during Monitored Anesthesia Care in high-risk cardiac
patients undergoing placement of implantable cardioverter deﬁ-
brillator. In this study, it has been proved that there is a greater
incidence of intraoperative upper airway obstruction more than
apnea. Also, in this study, all patients received local anesthesia
with conscious sedation using different drugs including propo-
fol, midazolam and fentanyl. Episodes of apnea and upper air-
way obstruction were abolished by early intraoperative
interventions as verbal stimulation, jaw thrust and chin lift
maneuvers or placement of a nasal airway. So, the reduction
of such risky events during conscious sedation in these high risk
patients is very important in reducing the intra and postopera-
tive morbidity and mortality. The avoidance or the reduction
of the use of opioids during such procedure is important to min-
imize the respiratory events. Additionally, in the study done by
Bhananker et al. [19], to analyze the claims forMonitoredAnes-
thesia Care (MAC) from the American Society of Anesthesiolo-
gists (ASAs) Closed Claims database, they concluded that
adverse outcomes during MAC are on increase. The most com-
mon untoward effect is inadequate oxygenation/ventilation.
Also, claims involved the older population and the higher risk
or more sicker patients.
It is recommended to increase the use of intravenous para-
cetamol in conscious sedation for ICD placement in such high-
risk group of patients in order to reduce pain as well as to min-
imize the deleterious respiratory events which might happen
especially with the use of large dose of opioids. Some limita-
tions were faced in this study, which were the limited number
of patients, also, evaluation of pain was difﬁcult where we used
a simple tool for all patients.
In conclusion, paracetamol is effective in reducing the fen-
tanyl use, so, reducing the incidence of intraoperative upper
airway obstruction and apnea. Although the degree of seda-
tion was signiﬁcantly lower in the paracetamol patients than
in those of the fentanyl group, paracetamol provides a good
analgesic effect than fentanyl alone by the end of the
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